vs
KINGSWAY FINANCIAL SERVICES INC(KFS)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
KINGSWAY FINANCIAL SERVICES INC的季度营收约是STANDARD BIOTOOLS INC.的2.0倍($38.6M vs $19.6M),KINGSWAY FINANCIAL SERVICES INC净利率更高(-4.1% vs -177.4%,领先173.3%),KINGSWAY FINANCIAL SERVICES INC同比增速更快(30.1% vs -11.5%),过去两年KINGSWAY FINANCIAL SERVICES INC的营收复合增速更高(21.4% vs -12.2%)
金斯威金融服务公司是一家专业金融控股企业,主要提供财产和意外伤害保险产品,包括个人车险、商业责任险、财产险等,核心市场覆盖北美地区,服务个人消费者、小微企业主及特定商业客户群体。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
KFS vs LAB — 直观对比
营收规模更大
KFS
是对方的2.0倍
$19.6M
营收增速更快
KFS
高出41.6%
-11.5%
净利率更高
KFS
高出173.3%
-177.4%
两年增速更快
KFS
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $38.6M | $19.6M |
| 净利润 | $-1.6M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 0.8% | -168.5% |
| 净利率 | -4.1% | -177.4% |
| 营收同比 | 30.1% | -11.5% |
| 净利润同比 | -7.8% | -28.8% |
| 每股收益(稀释后) | $-0.07 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
KFS
LAB
| Q4 25 | $38.6M | — | ||
| Q3 25 | $37.2M | $19.6M | ||
| Q2 25 | $30.9M | $21.8M | ||
| Q1 25 | $28.3M | $40.8M | ||
| Q4 24 | $29.6M | — | ||
| Q3 24 | $27.1M | $22.1M | ||
| Q2 24 | $26.4M | $22.5M | ||
| Q1 24 | $26.2M | $45.5M |
净利润
KFS
LAB
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-2.4M | $-34.7M | ||
| Q2 25 | $-3.2M | $-33.5M | ||
| Q1 25 | $-3.1M | $-26.0M | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-2.3M | $-26.9M | ||
| Q2 24 | $-2.2M | $-45.7M | ||
| Q1 24 | $-2.3M | $-32.2M |
毛利率
KFS
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率
KFS
LAB
| Q4 25 | 0.8% | — | ||
| Q3 25 | -2.3% | -168.5% | ||
| Q2 25 | -3.6% | -118.1% | ||
| Q1 25 | -2.5% | -80.8% | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | -2.5% | -120.9% | ||
| Q2 24 | 0.5% | -134.5% | ||
| Q1 24 | 2.9% | -132.2% |
净利率
KFS
LAB
| Q4 25 | -4.1% | — | ||
| Q3 25 | -6.5% | -177.4% | ||
| Q2 25 | -10.2% | -153.7% | ||
| Q1 25 | -10.9% | -63.8% | ||
| Q4 24 | -5.0% | — | ||
| Q3 24 | -8.5% | -122.0% | ||
| Q2 24 | -8.3% | -203.3% | ||
| Q1 24 | -8.9% | -70.6% |
每股收益(稀释后)
KFS
LAB
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.10 | $-0.09 | ||
| Q2 25 | $-0.13 | $-0.09 | ||
| Q1 25 | $-0.13 | $-0.07 | ||
| Q4 24 | $-0.08 | — | ||
| Q3 24 | $-0.10 | $-0.07 | ||
| Q2 24 | $-0.08 | $-0.12 | ||
| Q1 24 | $-0.09 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $129.4M |
| 总债务越低越好 | $70.7M | — |
| 股东权益账面价值 | $15.2M | $399.7M |
| 总资产 | $231.5M | $539.6M |
| 负债/权益比越低杠杆越低 | 4.66× | — |
8季度趋势,按日历期对齐
现金及短期投资
KFS
LAB
| Q4 25 | $8.5M | — | ||
| Q3 25 | $9.5M | $129.4M | ||
| Q2 25 | $12.3M | $158.6M | ||
| Q1 25 | $6.5M | $150.9M | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $6.7M | $210.6M | ||
| Q2 24 | $9.8M | $269.8M | ||
| Q1 24 | $12.3M | $287.1M |
总债务
KFS
LAB
| Q4 25 | $70.7M | — | ||
| Q3 25 | $70.7M | — | ||
| Q2 25 | $58.3M | — | ||
| Q1 25 | $59.5M | — | ||
| Q4 24 | $57.5M | — | ||
| Q3 24 | $58.5M | $55.2M | ||
| Q2 24 | $47.3M | $55.1M | ||
| Q1 24 | $47.1M | $55.0M |
股东权益
KFS
LAB
| Q4 25 | $15.2M | — | ||
| Q3 25 | $16.6M | $399.7M | ||
| Q2 25 | $17.4M | $424.5M | ||
| Q1 25 | $5.5M | $454.6M | ||
| Q4 24 | $8.4M | — | ||
| Q3 24 | $9.9M | $489.3M | ||
| Q2 24 | $20.7M | $510.3M | ||
| Q1 24 | $23.6M | $577.3M |
总资产
KFS
LAB
| Q4 25 | $231.5M | — | ||
| Q3 25 | $235.1M | $539.6M | ||
| Q2 25 | $207.7M | $557.0M | ||
| Q1 25 | $192.1M | $579.6M | ||
| Q4 24 | $186.6M | — | ||
| Q3 24 | $191.1M | $681.5M | ||
| Q2 24 | $192.3M | $708.7M | ||
| Q1 24 | $198.0M | $777.7M |
负债/权益比
KFS
LAB
| Q4 25 | 4.66× | — | ||
| Q3 25 | 4.25× | — | ||
| Q2 25 | 3.34× | — | ||
| Q1 25 | 10.91× | — | ||
| Q4 24 | 6.84× | — | ||
| Q3 24 | 5.88× | 0.11× | ||
| Q2 24 | 2.29× | 0.11× | ||
| Q1 24 | 2.00× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-3.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
KFS
LAB
| Q4 25 | $-3.0K | — | ||
| Q3 25 | $1.5M | $-22.2M | ||
| Q2 25 | $337.0K | $-20.7M | ||
| Q1 25 | $-1.8M | $-30.3M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $368.0K | $-27.9M | ||
| Q2 24 | $557.0K | $-39.0M | ||
| Q1 24 | $249.0K | $-62.5M |
自由现金流
KFS
LAB
| Q4 25 | — | — | ||
| Q3 25 | $1.3M | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率
KFS
LAB
| Q4 25 | — | — | ||
| Q3 25 | 3.4% | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度
KFS
LAB
| Q4 25 | — | — | ||
| Q3 25 | 0.5% | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KFS
| Other | $14.8M | 38% |
| Roundhouse Electric Equipment Co Inc | $9.7M | 25% |
| MLC Plumbing LLC | $5.7M | 15% |
| Systems Products International Incspi | $3.8M | 10% |
| Advanced Plumbing And Drain | $2.9M | 8% |
| Southside Plumbing | $1.7M | 4% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |